Bio Medica Laboratories
Bio Medica Laboratories (BMLL) share price was ₹154.90 at the 27 Oct 2026 close; market capitalisation ₹195 Cr; sector Healthcare. In the Mar 2026 quarter, revenue was ₹43 Cr and net profit was ₹12 Cr. Promoters held 67.70% of Bio Medica Laboratories in May 2026, down 32.30 percentage points from Aug 2025.
Key Fundamentals
SMEPharmaceuticals & BiotechnologyHealthcarePrice-based figures as of 27 Oct 2026, 15:30 IST · TTM
Peer Comparison
Healthcare › Pharmaceuticals
| ₹1,765.90 | 35.03 | 4,23,699 Cr | 5.07 | 0.91% | 13.79% | 17.94% | 61,848 Cr | 12,117 Cr | |
| ₹9,653.50 | 87.62 | 2,56,270 Cr | 15.29 | 0.32% | 15.32% | 18.96% | 11,682 Cr | 2,925 Cr | |
| ₹4,595.20 | 72.14 | 1,74,787 Cr | 9.51 | 0.82% | 12.16% | 9.06% | 17,058 Cr | 2,156 Cr | |
| ₹2,190.10 | 108.21 | 1,18,334 Cr | 22.33 | 0.09% | 16.38% | 19.67% | 7,323 Cr | 1,090 Cr | |
| ₹1,181.60 | 26.29 | 1,17,865 Cr | 4.35 | 0.09% | 16.99% | 19.24% | 28,515 Cr | 4,593 Cr | |
| ₹1,337.30 | 34.64 | 1,11,622 Cr | 2.88 | 0.61% | 10.87% | 13.94% | 34,247 Cr | 3,184 Cr | |
| ₹1,363.10 | 32.66 | 1,10,119 Cr | 3.11 | 0.96% | 11.21% | 14.88% | 28,589 Cr | 3,356 Cr | |
| ₹154.90 | — | 195 Cr | 2.64 | 0.00% | 58.44% | 34.20% | — | — | |
| Median 8 companies | ₹1,564.50 | 35.03 | 1,18,099 Cr | 4.71 | 0.47% | 14.56% | 18.45% | 28,515 Cr | 3,184 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Technical Indicators
Oscillators
Bearish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 46% · Mar 2026
Quarterly Results
| Particulars | Mar 2026 |
|---|---|
| Sales | 43 |
| Expenses | 23 |
| Operating Profit | 20 |
| OPM % | 46% |
| Other Income | 0 |
| Interest | 2 |
| Depreciation | 1 |
| PBT | 16 |
| Tax % | 27% |
| Net Profit | 12 |
| EPS (₹) | 13.06 |
Profit & Loss
| Particulars | Mar 2026 |
|---|---|
| Sales | 43 |
| Expenses | 23 |
| Operating Profit | 20 |
| OPM % | 46% |
| Other Income | 0 |
| Interest | 2 |
| Depreciation | 1 |
| PBT | 16 |
| Tax % | 27% |
| Net Profit | 12 |
| EPS (₹) | 13.06 |
| Div. Payout % | 0% |
Balance Sheet
| Particulars | Mar 2026 |
|---|---|
| Equity Capital | 9 |
| Reserves | 17 |
| Borrowings | 40 |
| Other Liabilities | 7 |
| Total Liabilities | 73 |
| Fixed Assets | 17 |
| CWIP | 0 |
| Investments | 0 |
| Other Assets | 56 |
| Total Assets | 73 |
Cash Flow
| Particulars | Mar 2026 |
|---|---|
| Operating | -6 |
| Investing | -2 |
| Financing | 8 |
| Net Cash Flow | 0 |
| Free Cash Flow | -8 |
| CFO/OP | -9 |
Ratios
| Particulars | Mar 2026 |
|---|---|
| Debtor Days | 92 |
| Inventory Days | 759 |
| Days Payable | 116 |
| Cash Conversion Cycle | 735 |
| Working Capital Days | 300 |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Bio Medica Laboratories insights
44 extracted metrics + investor summaries across FY25–FY26.
Documents
Frequently Asked Questions about Bio Medica Laboratories
What does Bio Medica Laboratories Ltd do?
Where is Bio Medica Laboratories Ltd (BMLL) listed?
Which sector does Bio Medica Laboratories Ltd belong to?
What is the market capitalisation of Bio Medica Laboratories Ltd?
What is the 52-week high and low of Bio Medica Laboratories Ltd?
What is the Return on Equity (ROE) of Bio Medica Laboratories Ltd?
Company Information
Incorporated in August 2015, Bio Medica Laboratories Ltd specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the -counter (OTC) medications[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/BMLL.md for Bio Medica Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.